Urovant Sciences GmbH and Sumitomo Pharma America Inc., subsidiaries of the Japan-based corporate parent, said the dispute with Intas and its Accord Healthcare unit “belongs in Delaware,” but they concurrently filed a complaint Thursday in the US District Court for the Eastern District of North Carolina “out of an abundance of caution,” since Accord is based in Raleigh, N.C.
Sumitomo Pharma filed in the District of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
